P04.1 Newborn affected by other maternal medication

Versions

1. 2025

   No changes

2. 2024

   Code changed

   View

   • Code first

     • • withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)
     • • , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
       • withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

3. 2023

   No changes

4. 2022

   No changes

5. 2021

   No changes

6. 2020

   No changes

7. 2019

   Code changed

   View

   • Code first

     • • withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)

   • Type 1 excludes

     • • dysmorphism due to warfarin (Q86.2)
       • fetal hydantoin syndrome (Q86.1)
       • maternal use of drugs of addiction (P04.4-)
     • • dysmorphism due to warfarin (Q86.2)
       • fetal hydantoin syndrome (Q86.1)

   • Type 2 excludes

     • • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
       • maternal use of drugs of addiction (P04.4-)

   • Inclusion term

     • • Newborn affected by cancer chemotherapy
       • Newborn affected by cytotoxic drugs

8. 2018

   No changes

9. 2017

   Code changed

   View

   • Description

     • • Newborn (suspected to be) affected by other maternal medication
     • • Newborn affected by other maternal medication

   • Inclusion term

     • • Newborn (suspected to be) affected by cancer chemotherapy
       • Newborn (suspected to be) affected by cytotoxic drugs
     • • Newborn affected by cancer chemotherapy
       • Newborn affected by cytotoxic drugs

   • Short description

     • • Newborn affected by oth maternal medication
     • • Newborn affected by other maternal medication

10. 2016

    New code